CMS reinstates enforcement discretion under CLIA for certain SARS-CoV-2 tests
![CMS Update pic](/sites/default/files/styles/900x400/public/2018-04/CMS%20Update%20pic.jpg?itok=Y6qkitGA)
During the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, the Centers for Medicare & Medicaid Services announced Friday. The decision rescinds a Sept. 26 memorandum that ended the 2020 enforcement discretion policy.
Related News Articles
Headline
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
The Centers for Disease Control and Prevention has updated respiratory syncytial virus vaccination recommendations for adults 60 and older. Adults aged 60-74…
Headline
The AHA along with the Association for the Health Care Environment recently released the Environmental Services Competency Resource Search Catalog, which…
Headline
Antimicrobial-resistant infections remained above pre-pandemic levels in 2022, the Centers for Disease Control and Prevention reported July 16. CDC data show…
Headline
The Centers for Disease Control and Prevention July 14 announced four confirmed human cases of H5N1 bird flu among farm workers who were working at a Colorado…